Stryker (NYSE:SYK) Hits New 1-Year Low – What’s Next?

Stryker Corporation (NYSE:SYK)’s stock price hit a new 52-week low during trading on Tuesday . The company traded as low as $290.22 and last traded at $291.2090, with a volume of 3089801 shares changing hands. The stock had previously closed at $294.73.

Wall Street Analyst Weigh In

Several research firms recently commented on SYK. Evercore set a $355.00 price target on Stryker in a research report on Friday, May 1st. Barclays lowered their price objective on Stryker from $469.00 to $394.00 and set an “overweight” rating for the company in a research note on Monday. Needham & Company LLC dropped their target price on Stryker from $454.00 to $418.00 and set a “buy” rating for the company in a report on Friday, May 1st. TD Cowen lowered Stryker from a “buy” rating to a “hold” rating and set a $387.00 price target on the stock. in a report on Monday, January 26th. Finally, Piper Sandler restated an “overweight” rating on shares of Stryker in a research report on Tuesday, January 27th. Sixteen research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $395.48.

Stryker Stock Down 1.1%

The firm has a market cap of $111.88 billion, a PE ratio of 33.81, a price-to-earnings-growth ratio of 1.86 and a beta of 0.80. The company has a 50-day simple moving average of $342.12 and a 200-day simple moving average of $355.73. The company has a debt-to-equity ratio of 0.62, a current ratio of 2.11 and a quick ratio of 1.25.

Stryker (NYSE:SYK) last issued its quarterly earnings results on Thursday, April 30th. The medical technology company reported $2.60 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.98 by ($0.38). The business had revenue of $6.02 billion for the quarter, compared to the consensus estimate of $6.34 billion. Stryker had a return on equity of 23.42% and a net margin of 13.20%.Stryker’s revenue was up 2.6% on a year-over-year basis. During the same period in the prior year, the business posted $2.84 earnings per share. Stryker has set its FY 2026 guidance at 14.900-15.100 EPS. Analysts expect that Stryker Corporation will post 14.97 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Stryker

A number of institutional investors and hedge funds have recently added to or reduced their stakes in SYK. Sankala Group LLC bought a new position in Stryker in the fourth quarter worth approximately $26,000. Godfrey Financial Associates Inc. purchased a new stake in shares of Stryker in the 4th quarter worth $26,000. United Financial Planning Group LLC bought a new position in shares of Stryker during the 3rd quarter worth $27,000. Atlas Capital Advisors Inc. purchased a new position in shares of Stryker during the fourth quarter valued at $27,000. Finally, DJE Kapital AG bought a new stake in shares of Stryker in the fourth quarter valued at about $28,000. Institutional investors own 77.09% of the company’s stock.

Stryker Company Profile

Stryker Corporation is a global medical technology company that designs, manufactures and markets a broad range of products and services for use in hospitals, surgeons’ offices and other healthcare facilities. Its primary business activities span orthopedics (including joint replacement implants, trauma and extremities products), surgical equipment and operating room technologies (such as visualization, navigation and powered instruments), neurotechnology and spine solutions, and patient-handling and emergency medical equipment.